Brain Cancer Trial, Recruiting NCT07631338 Sponsor: Hospital Italiano de Buenos Aires Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07631338
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Group 1:

  • You must be 18 years old or older and be a member of the health insurance plan at Hospital Italiano de Buenos Aires.
  • You must have had at least 1 year of documented medical follow-up during the study period.

Group 2:

  • You must be 18 years old or older and have been diagnosed with a low-grade brain tumor (called a low-grade glioma, WHO grades I or II) confirmed through a laboratory tissue test.

Who may not be able to join:

Group 1:

  • You are not enrolled in the health insurance plan at Hospital Italiano de Buenos Aires.

Group 2:

  • Your brain tumor diagnosis is incomplete, uncertain, or cannot be fully confirmed through tissue testing and molecular analysis.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ivan Alfredo Huespe, MD, MPh, Hospital Italiano de Buenos Aires

Phone: +5493425382554

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hospital Italiano de Buenos Aires
Registry
ClinicalTrials.gov
Start date
1 April 2026
Est. completion
1 February 2027

Where this trial is recruiting

🇦🇷 Argentina

Primary endpoints

Describe the incidence density of LGG; Generate an Argentine population projection model; Describe overall survival (OS) and disease-free survival (DFS); Describe the treatment strategies implemented in patients with LGG in public and private institutions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov